Cardiac disease from accelerated FEV₁ decline and acute exacerbations: time to rethink comorbidities in COPD

Eur Respir J. 2021 Mar 4;57(3):2004008. doi: 10.1183/13993003.04008-2020. Print 2021 Mar.

Author

Yunus Çolak^{1

2

3}

Affiliations

¹ Dept of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark yunus.colak@regionh.dk yunuscol@gmail.com.
² The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
³ Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

PMID: 33664099
DOI: 10.1183/13993003.04008-2020

No abstract available

Publication types

Editorial
Comment

MeSH terms

Forced Expiratory Volume
Heart Diseases*
Humans
Pulmonary Disease, Chronic Obstructive* / complications
Pulmonary Disease, Chronic Obstructive* / epidemiology
Respiratory Function Tests